Bing Xing Li

20210002345, Jan 7, 2021

Mar 18, 2019

16/980579

Ahmet KEKEC - Kenilworth NJ, US
Nancy Jo KEVIN - Kenilworth NJ, US
Bing LI - Kenilworth NJ, US
Songnian LIN - Kenilworth NJ, US
Craig A. PARISH - Kenilworth NJ, US
Weijuan TANG - Rahway NJ, US
- Rahway NJ, US

Merck Sharp & Dohme Corp. - Rahway NJ

C07K 14/62
C07K 1/107

The present invention relates to tyrosine-specific functionalized insulin analogs and processes of making such tyrosine-specific functionalized insulin analogs using R-3H-1,2,4-triazoline-3,5-(4H)diones (PTAD).

20180030036, Feb 1, 2018

Dec 7, 2015

15/534029

Ting ZHANG - Rahway NJ, US
Yi-Heng CHEN - Rahway NJ, US
Liangqin GUO - Rahway NJ, US
Alan HARUZA - Rahway NJ, US
Tianying JIAN - Rahway NJ, US
Bing LI - Rahway NJ, US
Dongfang MENG - Rahway NJ, US
Edward C. SHERER - Rahway NJ, US
Harold B. WOOD - Rahway NJ, US
Isao SAKURADA - Tokyo, JP
- Rahway NJ, US
- Tokyo, JP

MERCK SHARP & DOHME CORP. - Rahway NJ
MOCHIDA PHARMACEUTICAL CO., LTD - Tokyo

C07D 403/12
C07D 401/14
C07D 401/12
C07D 471/04

The present invention provides a compound of Formula I, and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing unstable angina, refractory angina, myocardial infarction, transient ischemic attacks, atrial fibrillation, thrombotic stroke, embolic stroke, deep vein thrombosis, disseminated intravascular coagulation, ocular build up of fibrin, and reocclusion or restenosis of recanalized vessels. The compounds are selective Factor IXa inhibitors.

20170286277, Oct 5, 2017

Mar 31, 2016

15/087450

- Islandia NY, US
Bing Li - Plainview NY, US

G06F 11/36
G06F 9/44

Transaction data is accessed that has been generated from monitoring of a plurality of transactions in a system that includes a plurality of software components. The transaction data is assessed to identify that a particular one of the plurality of transactions meets a particular one of a set of conditions based on an attribute of the particular transaction. A portion of the transaction data describing the particular transaction is selected based on the particular transaction meeting the particular condition. A model of a particular one of the software components involved in the particular transaction is generated using the selected portion of the transaction data. The model is used to launch a computer-implemented simulation of the particular software component within subsequent transactions of the system.